Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (731-740 of 751) with videos related to

Pageof 76
Sort By:
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Circulation. Cardiovascular Genetics|February 10, 2012
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complexRobert W Davies, George A Wells, Alexandre F R Stewart, et al.
Resuscitation|December 15, 2022
Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.
The New England Journal of Medicine|March 30, 2026
Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K Doshi, Saibal Kar, Devi G Nair, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
European Heart Journal|January 30, 2020
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working groupWilliam H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, et al.
American Journal of Human Genetics|July 24, 2004
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD StudyElizabeth R Hauser, David C Crossman, Christopher B Granger, et al.
The New England Journal of Medicine|November 12, 2023
Apixaban for Stroke Prevention in Subclinical Atrial FibrillationJeff S Healey, Renato D Lopes, Christopher B Granger, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2025
Overcoming Barriers to Developing and Implementing Novel Therapies for HypertensionKonstantin A Krychtiuk, Renato D Lopes, Victoria A Cargill, et al.
JAMA Cardiology|July 25, 2019
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical IllnessErin A Bohula, Jason N Katz, Sean van Diepen, et al.
Pageof 76

Showing results (731-740 of 751) with videos related to

Sort By:
Pageof 76
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Circulation. Cardiovascular Genetics|February 10, 2012
A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complexRobert W Davies, George A Wells, Alexandre F R Stewart, et al.
Resuscitation|December 15, 2022
Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.
The New England Journal of Medicine|March 30, 2026
Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K Doshi, Saibal Kar, Devi G Nair, et al.
Circulation|January 5, 2022
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and SexAnthony P Carnicelli, Hwanhee Hong, Stuart J Connolly, et al.
European Heart Journal|January 30, 2020
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working groupWilliam H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, et al.
American Journal of Human Genetics|July 24, 2004
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD StudyElizabeth R Hauser, David C Crossman, Christopher B Granger, et al.
The New England Journal of Medicine|November 12, 2023
Apixaban for Stroke Prevention in Subclinical Atrial FibrillationJeff S Healey, Renato D Lopes, Christopher B Granger, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2025
Overcoming Barriers to Developing and Implementing Novel Therapies for HypertensionKonstantin A Krychtiuk, Renato D Lopes, Victoria A Cargill, et al.
JAMA Cardiology|July 25, 2019
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical IllnessErin A Bohula, Jason N Katz, Sean van Diepen, et al.
Pageof 76